USTR §301 Public Hearing, Germany Pharmaceutical Underpayment Investigation

USTR is holding a public hearing as part of a §301 investigation into Germany's pricing practices for innovative pharmaceutical products, alleging persistent underpayment. The action could lead to retaliatory trade measures against German goods.